Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT02623751
Eligibility Criteria:
Inclusion Criteria:
* Postmenopausal women aged ≥ 20 and \< 75 years at the time of consent;
* Estrogen receptor positive and/or progesterone receptors positive;
* HER2-negative
* Nonresectable advanced or recurrent breast cancer previously treated with nonsteroidal aromatase inhibitor (AI), and planning to be treated with exemestane
Exclusion Criteria:
* Radiation therapy or immuno therapy within 14 days before the first dose of investigational product;
* Chemotherapy, biological medicines, other pharmacotherapy or major surgery within 21 days before the first dose of the investigational product;
* Prior chemotherapies of ≥ 3 regimens for advanced or recurrent breast cancer;
* Ongoing treatment with other investigational product
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
74 Years
Study:
NCT02623751
Study Brief:
Protocol Section:
NCT02623751